Special Issue "Nanotechnology and Cancer"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 May 2018)
Prof. Dr. Stefano Leporatti
CNR Nanotec-Istituto di Nanotecnologia, Via Monteroni, c/o Campus Ekotecne, 73100 Lecce (LE), Italy
Website | E-Mail
Interests: nanomedicine; cytomechanics; drug delivery; scanning force microscopy; polymer nanocapsules; halloysite clay nanotubes; drug nanocolloids; nano-micelles
This Special Issue of Cancers, “Nanotechnology and Cancer”, focuses on the application of nanotechnology in cancer, either as a novel therapy (e.g., drug delivery) and also as a new tool for diagnoses (e.g., lab-on-chip).
Nanotechnology is a field where the use and development of particles and/or devices on a nano-scale has future application in Medicine or in Oncology. A part of nanotechnology, called nanomedicine, uses nanoscience and nanoengineering to interact with life sciences. Nanotechnology is, therefore, expected to lead to the development of novel tools, such as micro- and nano-devices or nano-particles for diagnosis and therapy.
This Special Issue will focus on use of nanotechnology to treat and/or diagnose cancer. The publication of original articles will contribute to the progress in the area of Nanomedicine and Oncology, and will further stimulate the entering into clinical praxis of these new tools and devices, envisaging the possible use of nanotechnology in defeating cancer.
Prof. Stefano Leporatti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Drug Delivery
- Micro and Nano-devices
- Theranostic Tools